AVITA Medical, Inc. Stock Other OTC
Equities
AVHHL
AU000000AVH4
Biotechnology & Medical Research
Sales 2024 * | 113M 75.72M 103M | Sales 2025 * | 158M 105M 144M | Capitalization | 356M 238M 324M |
---|---|---|---|---|---|
Net income 2024 * | -66M -44.08M -60.11M | Net income 2025 * | -32M -21.37M -29.15M | EV / Sales 2024 * | 2.77 x |
Net cash position 2024 * | 41.66M 27.82M 37.95M | Net Debt 2025 * | 1.53M 1.02M 1.39M | EV / Sales 2025 * | 2.27 x |
P/E ratio 2024 * |
-5.24
x | P/E ratio 2025 * |
-11.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on AVITA Medical, Inc.
1st Jan change | Capi. | |
---|---|---|
+48.64% | 54.63B | |
-6.44% | 39.92B | |
+37.07% | 38.82B | |
+14.28% | 26.86B | |
-11.17% | 26.22B | |
-21.40% | 18.78B | |
+25.64% | 12.21B | |
+0.96% | 12.16B | |
+27.04% | 11.94B |